David Rodman
2022
In 2022, David Rodman earned a total compensation of $1.1M as Chief Medical Officer at Mineralys Therapeutics.
Compensation breakdown
| Bonus | $71,544 |
|---|---|
| Non-Equity Incentive Plan | $119,241 |
| Option Awards | $492,064 |
| Salary | $411,458 |
| Other | $12,200 |
| Total | $1,106,507 |
Rodman received $492.1K in option awards, accounting for 44% of the total pay in 2022.
Rodman also received $71.5K in bonus, $119.2K in non-equity incentive plan, $411.5K in salary and $12.2K in other compensation.
Rankings
In 2022, David Rodman's compensation ranked 2,835th out of 5,760 executives tracked by ExecPay. In other words, Rodman earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,835 out of 5,760 | 51st |
Division Manufacturing | 1,581 out of 3,136 | 50th |
Major group Chemicals And Allied Products | 732 out of 1,422 | 49th |
Industry group Drugs | 684 out of 1,323 | 48th |
Industry Pharmaceutical Preparations | 494 out of 969 | 49th |
Source: SEC filing on April 9, 2024.
Rodman's colleagues
We found two more compensation records of executives who worked with David Rodman at Mineralys Therapeutics in 2022.